Home

Investor Relations

Company Profile

Corporate Governance

Stock Information

Analysts Coverage

Email Alerts

Press Room

Press Releases

Presentations & Recent Events

Investor Fact Sheet

Request Materials

EnteroMedics FAQ

Abstracts and Articles

Contact Information

Annual Report and Proxy

SEC Filings

Investor FAQs

Shareholder Briefcase

 

 

Press Room

Welcome to the EnteroMedics press room. This resource is intended for media professionals and investors who would like to learn more about EnteroMedics and VBLOCTM vagal blocking therapy. For press inquiries, please contact Greg S. Lea , Senior Vice President and Chief Financial Officer, EnteroMedics Inc., 651.789.2860, ir@enteromedics.com.


 

 

Home | What is VBLOC® Therapy? | Why VBLOC® Therapy?
Bariatric Weight Loss Surgery | Investors | Careers | Privacy Policy

EnteroMedics - 2800 Patton Road - St. Paul, MN 55113
CAUTION: Investigational device. Limited by Federal law to investigational use.
This page revised May 2009.